NCT05570422 2026-04-08
A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01
Kortuc, Inc.
Phase 1 Recruiting
Clinical Trials
19 trialsNCT07472153 2026-03-16
PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer
N.N. Alexandrov National Cancer Centre
Phase 2/3 Recruiting
NCT07340489 2026-01-14
Serplulimab for Locally Advanced Cervical Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT06727617 2026-01-06
Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT06529809 2025-12-24
Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer
Washington University School of Medicine
Phase 1/2 Recruiting
NCT07167160 2025-12-18
Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial
Women's Hospital School Of Medicine Zhejiang University
Phase 2 Recruiting
NCT07244965 2025-11-24
Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer
Women's Hospital School Of Medicine Zhejiang University
Phase 2 Not yet recruiting
NCT02635360 2025-07-03
Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer
University of Virginia
Phase 2 Completed
NCT05857631 2025-04-15
PARCERII
Tata Memorial Centre
Phase NA Recruiting
NCT06353061 2025-01-14
Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer
Peking Union Medical College Hospital
Phase 2 Recruiting
NCT06692166 2024-11-22
A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 3 Recruiting
NCT03755739 2024-06-25
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
Phase 2/3 Recruiting
NCT04188847 2022-03-15
First-line Chemotherapy for Recurrent Cervical Cancer
Peking Union Medical College Hospital
Phase 2 Completed
NCT03955367 2022-02-23
Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer
Peking Union Medical College Hospital
Phase 3 Unknown
NCT04635956 2020-11-19
Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas
Peking Union Medical College Hospital
Phase 2 Unknown
NCT03332069 2017-11-07
mEHT
University of Witwatersrand, South Africa
Phase 3 Unknown
NCT03238261 2017-08-11
Chemotherapy / Radiotherapy in Uterine Cervical Neoplasms
Instituto Nacional de Cancerologia, Columbia
Phase NA Completed
NCT03175848 2017-07-21
Chemotherapy Plus Radiation Therapy in Treating Patients With Primary Stage IVB Cervical Cancer
Zhejiang Cancer Hospital
Phase NA Unknown
NCT01917695 2015-08-13
Study on Early Stage Bulky Cervical Cancers
Government Royapettah Hospital
Phase 3 Unknown